Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?

References

• Behl, M., Zhang, Y., & Zheng, W. (2009). Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure. Cerebrospinal Fluid Research, 6, 11.
   PubMedGoogle Scholar
• Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy minimization and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.
   Web of Science ®Google Scholar
• Chang, Y. C., Chang, T. J., Jiang, Y. D., Kuo, S. S., Lee, K. C., Chin, K. C., & Chuang, L. M. (2007). Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the chinese population. Diabetes, 56, 2631–2637.
   PubMed Web of Science ®Google Scholar
• Chang, T. T., Chen, K. C., Chang, K. W., Chen, H. Y., Tsai, F. J., Sun, M. F., & Chen, C. Y. C. (2011). In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular Biosystems, 7, 2702–2710.
   PubMed Web of Science ®Google Scholar
• Chang, T. N., Huang, S. S., Chang, Y. S., Chang, C. I., Yang, H. L., Deng, J. S., & Huang, G. J. (2011). Analgesic effects and mechanisms of anti-inflammation of taraxeren-3-one from Diospyros maritima in mice. Journal of Agricultural and Food Chemistry, 59, 9112–9119.
   PubMed Web of Science ®Google Scholar
• Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011). High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Molecular Biosystems, 7, 3366–3374.
   PubMed Web of Science ®Google Scholar
• Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011). Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology, 7, e1002315.
   PubMed Web of Science ®Google Scholar
• Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Fisher, M., Lin, J. G., & Chen, C. Y. C. (2011). Screening from the world’s largest TCM database against H1N1 virus. Journal of Biomolecular Structure & Dynamics, 28, 773–786.
   PubMed Web of Science ®Google Scholar
• Chang, K. W., Tsai, T. Y., Chen, K. C., Yang, S. C., Huang, H. J., Chang, T. T., & Chen, C. Y. C. (2011). iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design. Journal of Biomolecular Structure & Dynamics, 29, 243–250.
   PubMed Web of Science ®Google Scholar
• Chang, P. C., Wang, J. D., Lee, M. M., Chang, S. S., Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). Lose weight with traditional chinese medicine? Potential suppression of fat mass and obesity-associated protein. Journal of Biomolecular Structure & Dynamics, 29, 471–483.
   PubMed Web of Science ®Google Scholar
• Chen, C. Y. C. (2007). The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor. Journal of the Chinese Chemical Society, 54, 653–658.
   Web of Science ®Google Scholar
• Chen, C. Y. C. (2010). Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors. Journal of the Taiwan Institute of Chemical Engineers, 41, 143–149.
   Web of Science ®Google Scholar
• Chen, C. Y. C. (2011). TCM database@Taiwan: The world’s largest traditional Chinese medicine database for drug screening in silico. PLoS ONE, 6, e15939.
   PubMed Web of Science ®Google Scholar
• Chen, C. Y. C. (2012). Mechanism of BAG1 repair on Parkinson’s disease-linked DJ1 mutation. Journal of Biomolecular Structure & Dynamics, 30, 1–12.
   PubMed Web of Science ®Google Scholar
• Chen, K. Y., Chang, S. S., & Chen, C. Y. C. (2012). In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine. PLoS ONE, 7, e43932.
   Google Scholar
• Chen, K. C., Chang, K. W., Chen, H. Y., & Chen, C. Y. C. (2011). Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular Biosystems, 7, 2711–2719.
   PubMed Web of Science ®Google Scholar
• Chen, K. C., Chang, S. S., Huang, H. J., Lin, T. L., Wu, Y. J., & Chen, C. Y. (2012). Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure and Dynamics, 30, 662–683.
   Google Scholar
• Chen, K. C., & Chen, C. Y. C. (2011). Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter, 7, 4001–4008.
   Web of Science ®Google Scholar
• Chen, C. Y. C., Chen, G. W., & Chen, W. Y. C. (2008). Molecular simulation of HER2/neu degradation by inhibiting HSP90. Journal of the Chinese Chemical Society, 55, 297–302.
   Web of Science ®Google Scholar
• Chen, C. Y., Huang, H. J., Tsai, F. J., & Chen, C. Y. C. (2010). Drug design for Influenza A virus subtype H1N1. Journal of the Taiwan Institute of Chemical Engineers, 41, 8–15.
   Web of Science ®Google Scholar
• Chen, K. C., Sun, M. F., Yang, S. C., Chang, S. S., Chen, H. Y., Tsai, F. J., & Chen, C. Y. C. (2011). Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology & Drug Design, 78, 679–688.
   PubMed Web of Science ®Google Scholar
• Choi, S. Y., Ahn, E. M., Song, M. C., Kim, D. W., Kang, J. H., Kwon, O. S., & Baek, N. I. (2005). In vitro GABA-transaminase inhibitory compounds from the root of Angelica dahurica. Phytotherapy Research: PTR, 19, 839–845.
   PubMed Web of Science ®Google Scholar
• Doi, K., Kojima, T., Makino, M., Kimura, Y., & Fujimoto, Y. (2001). Studies on the constituents of the leaves of Morus alba L. Chemical & Pharmaceutical Bulletin, 49, 151–153.
   PubMed Web of Science ®Google Scholar
• Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998). Insulin degradation: Progress and potential. Endocrine Reviews, 19, 608–624.
   PubMed Web of Science ®Google Scholar
• Fletcher, R. (1969). Optimization. New York, NY: Academic Press.
   Google Scholar
• Fletcher, R., & Reeves, C. M. (1964). Function minimization by conjugate gradients. Computer Journal, 7, 149–154.
   Web of Science ®Google Scholar
• Florez, J. C., Wiltshire, S., Agapakis, C. M., Burtt, N. P., de Bakker, P. I., Almgren, P., & Groop, L. (2006). High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes, 55, 128–135.
   PubMed Web of Science ®Google Scholar
• Groves, C. J., Wiltshire, S., Smedley, D., Owen, K. R., Frayling, T. M., Walker, M., & McCarthy, M. I. (2003). Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes, 52, 1300–1305.
   PubMed Web of Science ®Google Scholar
• Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.
   PubMed Web of Science ®Google Scholar
• Hu, C., Wang, C., Zhang, R., Ma, X., Wang, J., Lu, J., & Jia, W. (2009). Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia, 52, 1322–1325.
   PubMed Web of Science ®Google Scholar
• Huang, H. J., Yu, H. W., Chen, C. Y., Hsu, C. H., Chen, H. Y., Lee, K. J., & Chen, C. Y. C. (2010). Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers, 41, 623–635.
   Web of Science ®Google Scholar
• Im, H., Manolopoulou, M., Malito, E., Shen, Y., Zhao, J., Neant-Fery, M., & Tang, W. J. (2007). Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. The Journal of Biological Chemistry, 282, 25453–25463.
   PubMed Web of Science ®Google Scholar
• Jirovsky, D., Kosina, P., Myslinova, M., Styskala, J., Ulrichova, J., & Simanek, V. (2007). HPLC analysis of rosmarinic acid in feed enriched with aerial parts of Prunella vulgaris and its metabolites in pig plasma using dual-channel coulometric detection. Journal of Agricultural and Food Chemistry, 55, 7631–7637.
   PubMed Web of Science ®Google Scholar
• Karamohamed, S., Demissie, S., Volcjak, J., Liu, C., Heard-Costa, N., Liu, J., & Herbert, A. (2003). Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham heart study. Diabetes, 52, 1562–1567.
   PubMed Web of Science ®Google Scholar
• Kuo, W. L., Gehm, B. D., & Rosner, M. R. (1991). Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Molecular Endocrinology, 5, 1467–1476.
   PubMedGoogle Scholar
• Leissring, M. A., Malito, E., Hedouin, S., Reinstatler, L., Sahara, T., Abdul-Hay, S. O., & Selkoe, D. J. (2010). Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE, 5, e10504.
   PubMed Web of Science ®Google Scholar
• Lin, C. H., Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Chang, K. L., & Chen, C. Y. C. (2011). Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. Journal of Biomolecular Structure & Dynamics, 28, 471–482.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3–26.
   PubMed Web of Science ®Google Scholar
• Perlman, R. K., Gehm, B. D., Kuo, W. L., & Rosner, M. R. (1993). Functional analysis of conserved residues in the active site of insulin-degrading enzyme. The Journal of Biological Chemistry, 268, 21538–21544.
   PubMed Web of Science ®Google Scholar
• Qian, Y., Lu, F., Dong, M., Lin, Y., Li, H., Chen, J., & Shen, H. (2012). Genetic variants of IDE-KIF11-HHEX at 10q23.33 associated with type 2 diabetes risk: a fine-mapping study in Chinese population. PLoS ONE, 7, e35060.
   PubMedGoogle Scholar
• Ronn, T., Wen, J., Yang, Z., Lu, B., Du, Y., Groop, L., & Ling, C. (2009). A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia, 52, 830–833.
   PubMed Web of Science ®Google Scholar
• Shen, Y., Joachimiak, A., Rosner, M. R., & Tang, W. J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature, 443, 870–874.
   PubMed Web of Science ®Google Scholar
• Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 365, 1333–1346.
   PubMed Web of Science ®Google Scholar
• Sun, M. F., Chang, T. T., Chang, K. W., Huang, H. J., Chen, H. Y., Tsai, F. J., & Chen, C. Y. C. (2011). Blocking the DNA repair system by traditional Chinese medicine? Journal of Biomolecular Structure & Dynamics, 28, 895–906.
   PubMed Web of Science ®Google Scholar
• Sun, M. F., Chen, H. Y., Tsai, F. J., Liu, S. H., Chen, C. Y., & Chen, C. Y. C. (2011). Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: Identifying DNA repair protein XRCC4 inhibitors. Journal of Biomolecular Structure & Dynamics, 29, 325–337.
   PubMed Web of Science ®Google Scholar
• Tou, W. I., & Chen, C. Y. C. (2012). Traditional Chinese medicine as dual guardians against hypertension and cancer? Journal of Biomolecular Structure and Dynamics, 30, 299–317.
   PubMed Web of Science ®Google Scholar
• Tou, W. I., & Chen, C. Y. (2012). In silico investigation of potential SRC kinase ligands from traditional Chinese medicine. PLoS ONE, 7, e33728.
   PubMed Web of Science ®Google Scholar
• Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). IScreen: world’s first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. Journal of Computer-Aided Molecular Design, 25, 525–531.
   PubMed Web of Science ®Google Scholar
• Tsai, K. N., Chen, G. W., & Chen, C. Y. C. (2012). A novel algorithm for identification of activated cryptic 5′ splice sites. Journal of Biomolecular Structure & Dynamics, 29, 1089–1099.
   PubMed Web of Science ®Google Scholar
• Tsai, F. J., Yang, C. F., Chen, C. C., Chuang, L. M., Lu, C. H., Chang, C. T., & Wu, J. Y. (2010). A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genetics, 6, e1000847.
   PubMed Web of Science ®Google Scholar
• Valentova, K., Truong, N. T., Moncion, A., de Waziers, I., & Ulrichova, J. (2007). Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro. Journal of Agricultural and Food Chemistry, 55, 7726–7731.
   PubMed Web of Science ®Google Scholar
• Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003). LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling, 21, 289–307.
   PubMed Web of Science ®Google Scholar
• Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein–ligand interactions. Protein Engineering, 8, 127–134.
   PubMedGoogle Scholar
• Wang, C., Hu, C., Zhang, R., Bao, Y., Ma, X., Lu, J., & Jia, W. (2009). Common variants of hepatocyte nuclear factor 1beta are associated with type 2 diabetes in a Chinese population. Diabetes, 58, 1023–1027.
   PubMed Web of Science ®Google Scholar
• Wen, J., Ronn, T., Olsson, A., Yang, Z., Lu, B., Du, Y. P., & Hu, R. M. (2010). Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS ONE, 5, e9153.
   PubMed Web of Science ®Google Scholar
• Wu, Y., Li, H. X., Loos, R. J. F., Yu, Z. J., Ye, X. W., Chen, L. H., & Lin, X. (2008). Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes, 57, 2834–2842.
   PubMed Web of Science ®Google Scholar
• Yang, S. C., Chang, S. S., & Chen, C. Y. C. (2011). Identifying HER2 inhibitors from natural products database. PLoS ONE, 6, e28793.
   PubMed Web of Science ®Google Scholar
• Yang, S. C., Chang, S. S., Chen, H. Y., & Chen, C. Y. C. (2011). Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology, 7, e1002189.
   PubMed Web of Science ®Google Scholar
• Yang, C. P., Huang, G. J., Huang, H. C., Chen, Y. C., Chang, C. I., Wang, S. Y., & Kuo, Y. H. (2012). A new butanolide compound from the aerial part of Lindera akoensis with anti-inflammatory activity. Molecules, 17, 6585–6592.
   PubMed Web of Science ®Google Scholar
• Zheng, J., He, J., Ji, B., Li, Y., & Zhang, X. (2007). Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pacific Journal of Clinical Nutrition, 16(1), 427–431.
   PubMed Web of Science ®Google Scholar
• Zhou, D. Z., Zhang, D., Liu, Y., Zhao, T., Chen, Z., Liu, Z., & He, L. (2009). The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. Journal of Human Genetics, 54, 433–435.
   PubMed Web of Science ®Google Scholar